EUR/USD Forecast: Breaking 1.15? EU leaders near breakthrough, vaccine hopes, technicals all point up


  • EUR/USD has been advancing as EU leaders are reportedly closer to striking a deal.
  • Hopes for progress on a vaccine are keeping markets despite rising cases. 
  • Monday's four-hour chart is pointing to further gains.

Turkish Bazar – Markets in the country that was rejected from entering the EU resemble negotiations between the continent's elite. Leaders in the old continent have been extending their haggling for the fourth day, trading to sign off on a recovery fund – and they are reportedly on the verge of a bargain.

The original EU Commission plan – backed by Germany, France and most of Europe – consisted of €500 billion in mutually funded grants to the hardest-hit countries. The program was held back by the "Frugal Four" – a group of rich countries led by Mark Rutte, the Dutch Prime Minister who insisted on conditionality and lower sums.

The latest from Brussels suggest that the "frugals" are willing to accept €390 billion in grants. Is this sum enough for a recovery in the coronavirus-struck continent? Will this compromise satisfy Italy, Spain Germany, and France?

Euro bulls seem to see it as a done deal and are not waiting for white smoke – EUR/USD is trading above 1.1460, at the highest since March. It is now vulnerable to the downside if the meeting breaks up without an accord, but leaders would not have extended talks if there was not a hope for a deal. 

Broader markets are mixed, with S&P futures pointing only marginally lower and failing to provide support to the safe-haven dollar. Coronavirus cases continue surging in the US, topping 3.7 million, while the death toll surpassed 140,000. Los Angeles may impose a strict lockdown while Florida COVID-19 infections are "out of control." 

President Donald Trump downplayed the developments once again, claiming without evidence that the US has the world's best mortality rate. His mishandling of the crisis is highly correlated to a fall in support, according to the latest opinion polls. Trump is trailing Biden by around 9%, a consistent level.

On the other hand, hopes for a coronavirus vaccine remain high. Richard Horton, Editor of The Lancet, tweeted this on Sunday:

His prestigious medical publication previously published updates on AstraZeneca's efforts to develop a COVID-19 vaccine. The tweet, alongside other global, pushes to develop immunization, keep markets optimistic. 

US fiscal support is gaining more attention as several of the emergency measures – such as federal unemployment benefits – are set to expire at the end of July. Trump will reportedly meet Republicans to discuss the next steps on Monday. 

The economic calendar features few events on Monday, leaving the scene to European leaders and to coronavirus developments. 

EUR/USD Technical Analysis

While the currency pair is at the highest levels in three months, the Relative Strength Index on the four-hour chart is still below 70 – outside overbought conditions. That implies further gains may be in store. EUR/USD is above the 50, 100, and 200 Simple Moving Averages, and momentum remains to the upside. 

All in all, bulls are in control.

The next prize is 1.1495, which was March's peak. Further above, the next levels to watch are 1.1515, 1.1570, and 1.1620, dating back to early 2019 and late 2018. 

Euro/dollar is trading above the previous high of 1.1452, which now turns to support. The next cushion is the daily low of 1.1410, followed by 1.1370, a stepping stone on the way up which converges with the 50 SMA. Further down, 1.1325 and 1.13 await it. 

More Central banks make way for governments to act and move markets, but there is only one real boss

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD corrects toward 0.6850, awaits US PCE Price Index

AUD/USD corrects toward 0.6850, awaits US PCE Price Index

AUD/USD is falling back toward 0.6850 in Friday's Asian trading, reversing from near 19-month peak. A tepid US Dollar bounce drags the pair lower but the downside appears called by the latest Chinese stimulus measures, which boost risk sentiment ahead of US PCE data. 

AUD/USD News
USD/JPY pares gains below 145.50 after Tokyo CPI inflation data

USD/JPY pares gains below 145.50 after Tokyo CPI inflation data

USD/JPY is paring back gains to trade below 145.50 in the Asian session on Friday, as Tokyo CPI inflation data keep hopes of BoJ rate hikes alive. However, intensifying risk flows on China's policy optimism support the pair's renewed upside. The focus shifts to the US PCE inflation data. 

USD/JPY News
Gold price consolidates below record high as traders await US PCE Price Index

Gold price consolidates below record high as traders await US PCE Price Index

Gold price climbed to a fresh all-time peak on Thursday amid dovish Fed expectations. The USD languished near the YTD low and shrugged off Thursday’s upbeat US data. The upbeat market mood caps the XAU/USD ahead of the key US PCE Price Index.

Gold News
Avalanche rallies following launch of incentive program for developers

Avalanche rallies following launch of incentive program for developers

Avalanche announced the launch of Retro9000 on Thursday as part of its larger Avalanche9000 upgrade. Retro9000 is a program designed to support developers with up to $40 million in grants for building on the Avalanche testnet.

Read more
RBA widely expected to keep key interest rate unchanged amid persisting price pressures

RBA widely expected to keep key interest rate unchanged amid persisting price pressures

The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.

Read more
Five best Forex brokers in 2024

Five best Forex brokers in 2024

VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals. 

Read More

Majors

Cryptocurrencies

Signatures